396 related articles for article (PubMed ID: 2965235)
1. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Klemm SA; Tunny TJ; Gordon RD
J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
[TBL] [Abstract][Full Text] [Related]
3. Altering angiotensin levels by administration of captopril or indomethacin, or by angiotensin infusion, contributes to an understanding of atrial natriuretic peptide regulation in man.
Klemm SA; Gordon RD; Tunny TJ; Hamlet SM
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):349-55. PubMed ID: 2978745
[TBL] [Abstract][Full Text] [Related]
4. Levels of atrial natriuretic peptide are not always consistent with atrial pressure: is there alternative regulation as evidenced in Gordon's and Bartter's syndromes?
Klemm SA; Gordon RD; Tunny TJ; Hawkins PG; Finn WL; Hamlet SM; Kewal NK; Purton KJ
Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):269-74. PubMed ID: 2525973
[TBL] [Abstract][Full Text] [Related]
5. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon's syndrome and in Bartter's syndrome.
Tunny TJ; Higgins BA; Gordon RD
Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):341-5. PubMed ID: 2942327
[TBL] [Abstract][Full Text] [Related]
7. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
8. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
Vierhapper H; Waldhäusl W
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358
[TBL] [Abstract][Full Text] [Related]
9. Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humans.
Shimamoto K; Nakagawa M; Fukuyama S; Ura N; Murakami H; Yonekura S; Iwakura M; Yamaguchi Y; Ise T; Saitoh S
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S59-62. PubMed ID: 2473353
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin and atrial natriuretic peptide in Bartter's syndrome.
Gordon RD; Tunny TJ; Klemm SA
N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775
[No Abstract] [Full Text] [Related]
11. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
[TBL] [Abstract][Full Text] [Related]
12. [Elevated atrial natriuretic peptide (ANP) levels and normotension in Bartter's syndrome in childhood].
Di Pietro A; Proverbio MR; Capuano F; Chianese F; Coletta S; Catera P
Pediatr Med Chir; 1993; 15(3):289-90. PubMed ID: 8415177
[TBL] [Abstract][Full Text] [Related]
13. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Norby L; Mark AL; Kaloyanides GJ
Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man.
McMurray JJ; Struthers AD
J Hypertens Suppl; 1987 Dec; 5(5):S59-62. PubMed ID: 2965232
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
16. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins and systolic blood pressure, but not angiotensin II, independently affect atrial natriuretic peptide levels in man.
Klemm SA; Gordon RD; Tunny TJ; Finn WL; Hornych A
Clin Exp Pharmacol Physiol; 1992 May; 19(5):323-6. PubMed ID: 1387841
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin and atrial natriuretic peptide on the cerebral circulation.
Tamaki K; Saku Y; Ogata J
J Cereb Blood Flow Metab; 1992 Mar; 12(2):318-25. PubMed ID: 1532178
[TBL] [Abstract][Full Text] [Related]
19. Effect of human atrial natriuretic peptide on angiotensin II-induced secretion of aldosterone in man.
Vierhapper H
Klin Wochenschr; 1986; 64 Suppl 6():50-2. PubMed ID: 2948063
[TBL] [Abstract][Full Text] [Related]
20. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
